Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yushen Wu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|May 3, 2021
ATP2C2 Has Potential to Define Tumor Microenvironment in Breast CancerJiazhou Liu, Yuxian Wei, Yushen Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 14, 2020
Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysisChongfa Chen, Yi Jiang, Fang Yang, et al.
Frontiers in Immunology|August 24, 2019
Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint BlockadeBailin Niu, Fachun Zhou, Yanxin Su, et al.
Biochemical and Biophysical Research Communications|March 27, 2020
CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axisMengqi Lu, Yushen Wu, Beilei Zeng, et al.
International Journal of Surgery (London, England)|December 20, 2024
Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studiesMengxue Wang, Xunjia Li, Yushen Wu, et al.
Biochemical and Biophysical Research Communications|September 26, 2018
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancerBeilei Zeng, Yunhai Li, Yixiao Feng, et al.
International Journal of Biological Sciences|May 11, 2022
ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistanceJiefeng Huang, Jie Li, Jun Tang, et al.
Cancer Immunology Research|November 27, 2024
Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade TherapyJiazheng Sun, Pin Wang, Ziying Yi, et al.
Nature Communications|September 1, 2025
AEBP1 drives fibroblast-mediated T cell dysfunction in tumorsXiaoyu Wang, Jie Li, Daqiang Song, et al.
Theranostics|July 14, 2022
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblastsYushen Wu, Ziying Yi, Jie Li, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 3, 2021
ATP2C2 Has Potential to Define Tumor Microenvironment in Breast CancerJiazhou Liu, Yuxian Wei, Yushen Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 14, 2020
Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysisChongfa Chen, Yi Jiang, Fang Yang, et al.
Frontiers in Immunology|August 24, 2019
Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint BlockadeBailin Niu, Fachun Zhou, Yanxin Su, et al.
Biochemical and Biophysical Research Communications|March 27, 2020
CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axisMengqi Lu, Yushen Wu, Beilei Zeng, et al.
International Journal of Surgery (London, England)|December 20, 2024
Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studiesMengxue Wang, Xunjia Li, Yushen Wu, et al.
Biochemical and Biophysical Research Communications|September 26, 2018
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancerBeilei Zeng, Yunhai Li, Yixiao Feng, et al.
International Journal of Biological Sciences|May 11, 2022
ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistanceJiefeng Huang, Jie Li, Jun Tang, et al.
Cancer Immunology Research|November 27, 2024
Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade TherapyJiazheng Sun, Pin Wang, Ziying Yi, et al.
Nature Communications|September 1, 2025
AEBP1 drives fibroblast-mediated T cell dysfunction in tumorsXiaoyu Wang, Jie Li, Daqiang Song, et al.
Theranostics|July 14, 2022
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblastsYushen Wu, Ziying Yi, Jie Li, et al.
Pageof 3